SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-052967
Filing Date
2023-04-28
Accepted
2023-04-28 16:13:36
Documents
5
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232169-1_def14a.htm DEF 14A 588228
2 GRAPHIC lg_gaintherapeutics-4c.jpg GRAPHIC 31777
3 GRAPHIC px_01pgproxy-bw.jpg GRAPHIC 725465
4 GRAPHIC px_02pgproxy-bw.jpg GRAPHIC 837251
5 GRAPHIC sg_evanballantyue-bw.jpg GRAPHIC 10092
  Complete submission text file 0001104659-23-052967.txt   2547949
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40237 | Film No.: 23866301
SIC: 2834 Pharmaceutical Preparations